The Newest Diabetes Drugs on the Market - Verywell Health
WEBNov 1, 2023 · Many new medication options have been developed for type 1 or type 2 diabetes in recent years. The newest treatment options include medications taken by mouth, synthetic insulins, as well as injectables. Keep in mind that certain medications may lead to side effects in some individuals.
Recent Advances in Insulin Therapy - PMC - National Center for ...
WEBDec 7, 2020 · Recent advances in insulin therapy include ultra-rapid-acting insulin and ultra-long-acting basal insulin therapies. The focus of basal insulin development is toward longer and flatter profiles of action to reduce hypoglycemia and provide more flexibility with timing of dosing.
FDA Approves First Interchangeable Biosimilar Insulin Product …
WEBToday, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type...
Ultra-Rapid-Acting Insulins: How Fast Is Really Needed?
WEBOct 1, 2021 · The new generation of ultra-rapid-acting insulins, including faster aspart and URLi, offers additional bolus insulin options for patients with type 1 or type 2 diabetes.
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin ...
WEBSep 22, 2020 · Once-weekly treatment with insulin icodec had glucose-lowering efficacy and a safety profile similar to those of once-daily insulin glargine U100 in patients with …
On the Horizon – a Weekly Insulin, Oral Insulin, Smart ... - DiaTribe
WEBJun 7, 2022 · Learn what new insulin options may be on the horizon that could revolutionize the way diabetes is managed. In 2021, the world celebrated 100 years of insulin. Over those 100 years, insulin has revolutionized diabetes treatment, turning type 1 diabetes from a terminal disease to a chronic condition. …
Rezvoglar: New Insulin Glargine Biosimilar Provides Insulin
WEBJan 3, 2022 · The FDA recently announced its approval of Rezvoglar (insulin glargine-aglr), a new long-acting basal insulin, for adults and children with type 1 diabetes and adults with type 2 diabetes. Rezvoglar was approved as a …
FDA Approves Insulin Product
WEBJun 11, 2020 · Today, the U.S. Food and Drug Administration approved a new insulin product, indicated to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults...
Second-Generation Insulin Analogues – a Review of Recent …
WEBMay 11, 2018 · While providing similar efficacy in lowering HbA 1c to first-generation insulin analogues, the newer insulin treatment options provide additional clinical benefits, including a more stable, ultra-long duration of action that enables once-daily administration with flexibility in daily injection time, together with a lower risk of hypoglycaemia.
Engineering an Insulin Complex to Treat Diabetes | New England …
WEBJun 19, 2024 · The study by Zhang et al. adds to the growing body of work on GRIs and provides proof of concept on a biodegradable insulin complex formulation that releases insulin in a glucose-responsive...